GENERALIZED MYASTHENIA GRAVIS
Clinical trials for GENERALIZED MYASTHENIA GRAVIS explained in plain language.
Never miss a new study
Get alerted when new GENERALIZED MYASTHENIA GRAVIS trials appear
Sign up with your email to follow new studies for GENERALIZED MYASTHENIA GRAVIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New dosing strategy for myasthenia gravis drug shows promise
Disease control CompletedThis study tested two different ways of giving the drug efgartigimod to people with generalized myasthenia gravis, a condition that causes muscle weakness. One group received the drug continuously, while the other got it in cycles. The goal was to see which schedule works better …
Matched conditions: GENERALIZED MYASTHENIA GRAVIS
Phase: PHASE3 • Sponsor: argenx • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New Auto-Injector lets MG patients Self-Dose at home
Disease control CompletedThis study tested whether people with generalized myasthenia gravis (gMG) can safely and effectively use an auto-injector to give themselves the drug zilucoplan at home. Thirty-one adults who were already on a stable dose of zilucoplan took part. The main goal was to see if they …
Matched conditions: GENERALIZED MYASTHENIA GRAVIS
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New drug shows promise for Long-Term control of rare Muscle-Weakening disease
Disease control CompletedThis study tested the long-term safety of efgartigimod injections in 184 people with generalized myasthenia gravis, a chronic disease that causes muscle weakness. Participants received repeated treatment cycles over time. The goal was to see if the drug is safe and tolerable when…
Matched conditions: GENERALIZED MYASTHENIA GRAVIS
Phase: PHASE3 • Sponsor: argenx • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New drug shows promise for rare Muscle-Weakening disease
Disease control CompletedThis study tested a drug called rozanolixizumab in 200 adults with generalized myasthenia gravis, a condition that causes muscle weakness. The goal was to see if the drug improves daily activities and is safe compared to a placebo. Participants received either the drug or a dummy…
Matched conditions: GENERALIZED MYASTHENIA GRAVIS
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New shot could replace IV drips for rare muscle disease
Disease control CompletedThis study tested whether people with generalized myasthenia gravis could safely switch from intravenous (IV) infusions of complement inhibitors to daily injections of zilucoplan. Twenty-six participants who were stable on IV therapy switched to the subcutaneous shot. The main fo…
Matched conditions: GENERALIZED MYASTHENIA GRAVIS
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Jun 26, 2026 13:12 UTC
-
Home injection trial for myasthenia gravis shows promise
Symptom relief CompletedThis study tested whether 62 people with generalized myasthenia gravis could learn to self-administer the drug rozanolixizumab at home using a syringe driver or manual push. Participants were trained and then assessed on their ability to correctly give themselves the infusion. Th…
Matched conditions: GENERALIZED MYASTHENIA GRAVIS
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC